Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usageSamar Alsafadi, Marc‐Henri Stern|Nature Communications|2016Cited by 383
FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal MelanomaMalcy Tarin, Samar Alsafadi|Cancers|2023Cited by 15